DK1343896T3 - Lille syreoplöseligt sporeprotein og anvendelser deraf - Google Patents

Lille syreoplöseligt sporeprotein og anvendelser deraf

Info

Publication number
DK1343896T3
DK1343896T3 DK01996611T DK01996611T DK1343896T3 DK 1343896 T3 DK1343896 T3 DK 1343896T3 DK 01996611 T DK01996611 T DK 01996611T DK 01996611 T DK01996611 T DK 01996611T DK 1343896 T3 DK1343896 T3 DK 1343896T3
Authority
DK
Denmark
Prior art keywords
low acid
spore protein
soluble spore
soluble
protein
Prior art date
Application number
DK01996611T
Other languages
English (en)
Inventor
Heather Marie Fairhead
Original Assignee
Phico Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phico Therapeutics Ltd filed Critical Phico Therapeutics Ltd
Application granted granted Critical
Publication of DK1343896T3 publication Critical patent/DK1343896T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pest Control & Pesticides (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Agronomy & Crop Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Dentistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK01996611T 2000-11-17 2001-11-16 Lille syreoplöseligt sporeprotein og anvendelser deraf DK1343896T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0028130.3A GB0028130D0 (en) 2000-11-17 2000-11-17 Polypeptide and uses thereof
PCT/GB2001/005061 WO2002040678A1 (en) 2000-11-17 2001-11-16 Small acid-soluble spore protein and uses thereof

Publications (1)

Publication Number Publication Date
DK1343896T3 true DK1343896T3 (da) 2007-04-10

Family

ID=9903398

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01996611T DK1343896T3 (da) 2000-11-17 2001-11-16 Lille syreoplöseligt sporeprotein og anvendelser deraf

Country Status (12)

Country Link
US (2) US7632512B2 (da)
EP (1) EP1343896B1 (da)
JP (1) JP4225780B2 (da)
AT (1) ATE348167T1 (da)
AU (2) AU2002223814B2 (da)
CA (1) CA2428662C (da)
DE (1) DE60125232T2 (da)
DK (1) DK1343896T3 (da)
ES (1) ES2276856T3 (da)
GB (1) GB0028130D0 (da)
PT (1) PT1343896E (da)
WO (1) WO2002040678A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0314469D0 (en) * 2003-06-20 2003-07-23 Phico Therapeutics Ltd Antimicrobial compositions and uses thereof
US7674621B2 (en) 2004-05-21 2010-03-09 The United States Of America As Represented By The Department Of Health And Human Services Plasmids and phages for homologous recombination and methods of use
FR2910492B1 (fr) * 2006-12-20 2013-02-15 Bio Modeling Systems Ou Bmsystems Procede de preparation de bacteriophages modifies par insertion de sequences aleatoires dans les proteines de ciblage desdits bacteriophages
GB0715416D0 (en) * 2007-08-07 2007-09-19 Phico Therapeutics Ltd Modified bacteriophage
GB201417810D0 (en) 2014-10-08 2014-11-19 Phico Therapeutics Ltd Modifying bacteriophage
GB201417808D0 (en) * 2014-10-08 2014-11-19 Phico Therapeutics Ltd Modified bacteriophage
GB201417811D0 (en) * 2014-10-08 2014-11-19 Phico Therapeutics Ltd Modifying bacteriophage
GB201417805D0 (en) 2014-10-08 2014-11-19 Phico Therapeutics Ltd Modifield bacteriophage
JP7166244B2 (ja) 2016-04-08 2022-11-07 フィコ セラピューティクス リミテッド 改変バクテリオファージ
LT3440200T (lt) 2016-04-08 2021-05-25 Phico Therapeutics Ltd Modifikuotas bakteriofagas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995027043A1 (en) 1994-04-05 1995-10-12 Exponential Biotherapies, Inc. Antibacterial therapy with genotypically modified bacteriophage
CA2329908A1 (en) 1998-04-24 1999-11-04 The Regents Of The University Of California Targeted gene delivery to cells by filamentous bacteriophage
WO2000003018A2 (en) * 1998-07-10 2000-01-20 Loyola University Of Chicago Antibiotic protein and method of production
CA2430501A1 (en) 2000-01-11 2001-07-19 Intralytix, Inc. Method for produce sanitation using bacteriophages

Also Published As

Publication number Publication date
ES2276856T3 (es) 2007-07-01
CA2428662C (en) 2010-10-05
JP2004513647A (ja) 2004-05-13
PT1343896E (pt) 2007-02-28
ATE348167T1 (de) 2007-01-15
US20100209393A1 (en) 2010-08-19
DE60125232T2 (de) 2007-05-31
EP1343896A1 (en) 2003-09-17
US7632512B2 (en) 2009-12-15
CA2428662A1 (en) 2002-05-23
GB0028130D0 (en) 2001-01-03
WO2002040678A1 (en) 2002-05-23
US20040097705A1 (en) 2004-05-20
US8133498B2 (en) 2012-03-13
AU2381402A (en) 2002-05-27
DE60125232D1 (de) 2007-01-25
JP4225780B2 (ja) 2009-02-18
EP1343896B1 (en) 2006-12-13
AU2002223814B2 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
CY1108007T1 (el) Φαρμακευτικες συνθεσεις βοτουλινικης τοξινης
DK1091975T3 (da) Ny cyclosporin med forbedret aktivitetsprofil
NL1015859A1 (nl) Farmaceutische preparaten.
DE60010098D1 (de) 28-epirapaloge
YU68002A (sh) Modifikovani faktor viii
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ATE380194T1 (de) 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
ATE330017T1 (de) Kallikrein gen
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
DE69435307D1 (de) Bazillus Thuringiensis und dessen insektizide Proteine
DE69938935D1 (de) Zyklische conotoxin-peptide
BR0108056A (pt) Preparados cosméticos com extratos waltheria indica
DK1343896T3 (da) Lille syreoplöseligt sporeprotein og anvendelser deraf
DE50111331D1 (de) Neue verwendung von proteinhydrolysaten
NO20031860L (no) Kahalalid F
DE60139544D1 (de) Veränderte, fluoreszierende proteine
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
ATE323722T1 (de) Antimikrobiell wirkendes peptid
HUP0202592A2 (hu) Lazofoxifen transzdermális adagolása
ATE305796T1 (de) Präparationen von vitamin e in kombination mit afamin
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
DE69807200D1 (de) Inklusionskomplexe in waessriger loesung
SE0300535D0 (sv) Treatment of burns